TTrialPathMatch Me to Trials
← Back to trials
RecruitingCancerSurvivorshipAnxiety

On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study is evaluating On-Trac (Online Training After Cancer), an online educational intervention to teach adult cancer survivors strategies to address anxiety based on Cognitive-Behavioral Therapy (CBT) and Acceptance Commitment Therapy (ACT) The name of the study intervention is Online Training After Cancer (On-Trac)

Sponsor: Dana-Farber Cancer Institute

You may qualify if…

  • ✓ Age ≥ 18
  • ✓ A diagnosis of cancer (except non-melanoma skin cancer) ≥ 12 months prior.
  • ✓ No active cancer therapy (excluding chemoprevention) in the past 4 months, and no further therapy planned.
  • ✓ Significant anxiety as evidenced by both of the following
  • ✓ Endorsement of the SCID ( Structured Clinical Interview for the DSM-5) Screener Items for Social Anxiety Disorder, Generalized Anxiety Disorder, Agoraphobia, Specific Phobia, or Illness Anxiety Disorder.
  • ✓ A score ≥ 6 on the Overall Anxiety Severity and Impairment Scale (OASIS).
  • ✓ Regular access to the internet.
  • ✓ Ability to read and write in English.

You may not qualify if…

  • ✕ Significant symptoms of Panic Disorder in the prior month, including anticipatory anxiety of having a future panic attack or avoidance symptoms associated with panic attacks, as assessed by three SCID-5 items from the panic attack disorder module.
  • ✕ Significant symptoms of Obsessive Compulsive Disorder, as evidenced by any obsessions over the past 3 months, as assessed by three SCID items from the Obsessive Compulsive Disorder module.
  • ✕ Psychiatric hospitalizations or emergency room visits for psychiatric care in the prior 2 years.
  • ✕ In the next two months, intention to use or likelihood of using emergent or "rescue" anxiety medication (e.g., Ativan, Xanax, Valium) or self-prescribed substances (i.e., marijuana) at the onset of anxiety symptoms or when entering a situation where they expect to experience anxiety.
  • ✕ Any significant marijuana use which could impact anxiety symptoms, as evidenced by one of the following:
  • ✕ 4 days of marijuana use in any week in the last month
  • ✕ 20 milligrams of THC (Tetrahydrocannabinol) products in any week in the last month.
  • ✕ Participation in any CBT or ACT-based behavioral or education intervention for anxiety in the past 2 years. This includes in-person, asynchronous, and synchronous online anxiety programs, and therapy that includes these skills. This does not include independent use of any self-help materials (i.e., workbooks, books).

Where it's recruiting

Source: ClinicalTrials.gov · NCT07305740 · last updated 2026-05-13